Your browser doesn't support javascript.
loading
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Seiler, Roland; Gibb, Ewan A; Wang, Natalie Q; Oo, Htoo Zarni; Lam, Hung-Ming; van Kessel, Kim E; Voskuilen, Charlotte S; Winters, Brian; Erho, Nicholas; Takhar, Mandeep M; Douglas, James; Vakar-Lopez, Funda; Crabb, Simon J; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Zwarthoff, Ellen C; Thalmann, George N; Davicioni, Elai; Boormans, Joost L; Dall'Era, Marc; van der Heijden, Michiel S; Wright, Jonathan L; Black, Peter C.
Afiliação
  • Seiler R; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. r_seiler@gmx.ch.
  • Gibb EA; Department of Urology, University Hospital Bern, Bern, Switzerland.
  • Wang NQ; GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
  • Oo HZ; GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
  • Lam HM; GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
  • van Kessel KE; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Voskuilen CS; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
  • Winters B; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Erho N; Division of Urology, Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Takhar MM; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
  • Douglas J; GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
  • Vakar-Lopez F; GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
  • Crabb SJ; Department of Urology, University Hospital of Southampton, Hampshire, United Kingdom.
  • van Rhijn BWG; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
  • Fransen van de Putte EE; Department of Medical Oncology, University Hospital of Southampton, Hampshire, United Kingdom.
  • Zwarthoff EC; Division of Urology, Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Thalmann GN; Division of Urology, Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Davicioni E; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Boormans JL; Department of Urology, University Hospital Bern, Bern, Switzerland.
  • Dall'Era M; GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
  • van der Heijden MS; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Wright JL; UC Davis Comprehensive Cancer Center, Sacramento, California.
  • Black PC; Department of Medical Oncology, University Hospital of Southampton, Hampshire, United Kingdom.
Clin Cancer Res ; 25(16): 5082-5093, 2019 08 15.
Article em En | MEDLINE | ID: mdl-30224344
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Biomarcadores Tumorais / Cisplatino / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Biomarcadores Tumorais / Cisplatino / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá